Biblio Discovery — Demo Discovery Service

21 results for "Sanda BURUIANA"

Showing 1–20 · 0.46 seconds · RSS

  1. Journal Article

    Istoricul sindromului antifosfolipidic.

    Sanda Buruiana

    Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol. 64 No. 4 · 2019 · Russian · DOAJ

    Este prezentat reviul literaturii care include istoricul etapelor studierii patogeniei, manifestărilor clinice și evoluției metodelor de diagnostic ale sindromului antifosfolipidic. Aprecierea cronologiei progreselor în cunoștințele medicale oferă informații utile despre patogenia, evoluția…

  2. Journal Article

    Diagnosticul și particularitățile clinice ale limfoamelor non-Hodgkin indolente.

    Sanda Buruiana; Maria Robu

    Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol. 59 No. 2-3 · 2018 · Russian · DOAJ

    Au fost studiate aspectele clinice și de diagnostic la 68 pacienți cu Limfoame non-Hodgkin (LNH) indolente cu vârsta cuprinsă între 27 și 79 de ani (bărbați-38, femei-30). Diagnosticul a fost confirmat histologic și imunohistochimic. LNH limfocitare din limfocite mici au fost identificate la 28…

  3. Journal Article Full text

    Clinical application of HALP score in the determination of nodal non-Hodgkin lymphoma prognosis

    Victor TOMACINSCHII; Sanda BURUIANA; Maria ROBU

    Documenta Haematologica, Vol. 1 No. 2 · 2023 · English · DOAJ

    Introduction: Non-Hodgkin’s lymphomas (NHL) are hematopoietic tumors that develop from the malignant proliferation of the lymphatic tissue. The onset of NHL can occur in any organ and tissue, at the same time the most frequent localization is represented by the primary involvement of the lymph…

  4. Journal Article

    ANTICARDIOLIPINIC ANTIBODIES IN NON-HODGKIN LYMPHOMA

    Sanda Buruiana; Minodora Mazur; Maria Robu et al.

    Hematology, Transfusion and Cell Therapy, Vol. 43 · 2021 · English · DOAJ Scopus

    Objective: Identification of hemostasis changes in patients with non-Hodgkin's lymphoma (NHL) and anticardiolipin antibodies (aCL). Methodology: The study included 83 patients (men-34, women-49) with a mean age of 63.2 years, with NHL, investigated complex, by research of lupus anticoagulant (LA)…

  5. Journal Article

    Hepatitis B and C infections among lymphoma patients: a national study in the Republic of Moldova

    Ivan Negara; Sanda Buruiana; Victor Tomacinschii et al.

    Journal of Infection in Developing Countries, Vol. 16 No. 12 · 2022 · English · DOAJ Scopus

    Introduction: Hepatitis B virus (HBV) and hepatitis C virus (HCV) represent common infections that are presumably associated with various types of lymphoma and specific clinical features. However, conclusive data are lacking and results from different regional studies are conflicting. Hence, a…

  6. Journal Article Full text

    Notch and Hedgehog Signaling Unveiled: Crosstalk, Roles, and Breakthroughs in Cancer Stem Cell Research

    Sabina Iluta; Madalina Nistor; Sanda Buruiana et al.

    Life, Vol. 15 No. 2 · 2025 · English · DOAJ Scopus

    The development of therapies that target cancer stem cells (CSCs) and bulk tumors is both crucial and urgent. Several signaling pathways, like Notch and Hedgehog (Hh), have been strongly associated with CSC stemness maintenance and metastasis. However, the extensive crosstalk present between these…

  7. Journal Article Full text

    Risk-Adapted Systemic Treatment Strategies in Multiple Myeloma: A Narrative Review

    Gheorghe BURUIANA; Sanda BURUIANA; Andrei OLARU et al.

    Modern Medicine, Vol. 33 No. 3 · 2026 · English · DOAJ Scopus

    Multiple myeloma is a biologically heterogeneous plasma cell malignancy characterized by highly variable clinical presentation, disease course and treatment response. Over the past two decades, the introduction of high-dose chemotherapy with autologous stem cell transplantation and the development…

  8. Journal Article Full text

    Real-World Outcomes and Morphological Patterns of Aggressive Non-Hodgkin Lymphoma in Moldova: A Five-Year Retrospective Cohort Study

    Artur ANTOSEL; Cristina DUDNIC; Maria ROBU et al.

    Documenta Haematologica, Vol. 4 No. 2 · 2026 · English · DOAJ

    Objectives: The addition of rituximab to CHOP chemotherapy has significantly improved outcomes in aggressive non-Hodgkin lymphoma (ANHL). However, data from resource-constrained healthcare systems remain limited. This study aimed to evaluate the clinical characteristics and treatment outcomes of…

  9. Journal Article Full text

    Assessing the quality of life in patients with non-Hodgkin’s lymphoma is a burden or an advantage?

    Sanda BURUIANA; Maria ROBU; Lucia MAZUR-NICORIC et al.

    Archives of the Balkan Medical Union, Vol. 55 No. 3 · 2020 · French · DOAJ Scopus

    Introduction. Non-Hodgkin’s lymphoma (NHL) is a malignant cancer of the lymphatic system. Modern treatment of NHL allows patients to extend their lifespan, but at the same time somatic and psychological complications reduce the patients’ quality of life. The objective of the study was to assess the…

  10. Journal Article

    Prevalența anticorpilor anticardiolipinici la pacienții cu limfom Non-Hodgkin

    Sanda Buruiana; Maria Robu; Lucia Mazur-Nicorici et al.

    Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol. 66 No. 2 · 2020 · Russian · DOAJ

    Din 62 pacienți cu limfom non-Hodgkin (LNH) aflați în staționar, Departamentul Hematologie a IMSPIO din RM, 47 au întrunit criteriile de includere în studiu. La vizita inițială vârsta medie a pacienților a fost de 64,1±1,3 (i-v 37-78) ani, durata bolii-4,3 (i-v 1-12) luni, iar femeile au constituit…

  11. Journal Article Full text

    Indolent non-Hodgkin lymphomas in the elderly

    Sanda BURUIANA; Maria ROBU; Lucia MAZUR-NICORICI et al.

    Archives of the Balkan Medical Union, Vol. 56 No. 3 · 2021 · French · DOAJ Scopus

    Introduction. Indolent non-Hodgkin lymphoma (NHL) is a lymphoid tumor with increasing morbidity with age. The objective of the study was to assess the clinical and hematological features of indolent NHL in elderly patients. Material and methods. The study included patients older than 60 years with…

  12. Journal Article Full text

    Antiphospholipid Antibodies in Non-Hodgkin's Lymphoma

    Sanda BURUIANA; Maria ROBU; Victor TOMACINSCHII et al.

    Documenta Haematologica, Vol. 3 No. 1 · 2025 · English · DOAJ

    Introduction: Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of malignant lymphoid tumors. Anticardiolipin (aCL), anti-β2 glycoprotein I (antiβ2GPI), lupus anticoagulant (LA) antibodies are found as NHL-associated acquired thrombophilic factors. Seropositivity of these antibodies in…

  13. Journal Article

    A case of relapsed acute myeloid leukemia mimicking acute otomastoiditis

    Ivan Negara; Inga Chemencedji; Natalia Dobrovolschi et al.

    Clinical Case Reports, Vol. 12 No. 4 · 2024 · English · DOAJ Dropped by Scopus 2021

    Key Clinical Message Identifying myeloid sarcoma in rare locations is a diagnostic challenge and requires careful evaluation. The optimal management of extramedullary disease requires further investigation, but tissue biopsy and a personalized approach are crucial. Abstract Herein, we describe an…

  14. Journal Article

    Aspectele clinice ale limfoamelor non-Hodgkin cu afectarea primară a ganglionilor limfatici abdominali.

    Maria Robu; Veronica Feghiu; Larisa Musteaţă et al.

    Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol. 59 No. 2-3 · 2018 · Russian · DOAJ

    Au fost studiate aspectele clinice la 65 pacienţi cu limfom non-Hodgkin cu afectarea primară a ganglionilor limfatici abdominali în vârstă de la 2 până la 73 de ani. Diagnosticul în toate cazurile a fost confirmat morfologic. S-a constatat că LNH cu afectarea primară a ganglionilor limfatici…

  15. Journal Article

    Aspectele clinice și rezultatele tratamentului leucemiei limfocitare cronice.

    Victor Tomacinschii; Maria Robu; Ion Corcimaru et al.

    Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol. 59 No. 2-3 · 2018 · Russian · DOAJ

    Au fost analizate particularitaţile evoluţiei clinice, prognostice și rezultatele nemijlocite ale tratamentului pe un lot de 118 pacienţi cu leucemie limfocitară cronică. Leucemia limfocitară cronică mai frecvent s-a dezvoltat la persoane cu vârsta 55-75 ani(69,4%), aproximativ cu aceeași frecvență…

  16. Journal Article Full text

    Advances in Cell and Immune Therapies for Melanoma

    Tanase Timis; Sanda Buruiana; Delia Dima et al.

    Biomedicines, Vol. 13 No. 1 · 2025 · English · DOAJ Scopus

    The incidence rate of cutaneous melanoma is on the rise worldwide, due to increased exposure to UV radiation, aging populations, and exposure to teratogen agents. However, diagnosis is more precise, and the increased number of new cases is related to the improved diagnosis tools. Despite better…

  17. Journal Article

    Policitemia vera: manifestările clinice şi rezultatele imediate şi la distanţă ale tratamentului

    Larisa Musteaţă; Ion Corcimaru; Maria Robu et al.

    Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, Vol. 59 No. 2-3 · 2018 · Russian · DOAJ

    Au fost analizate particularităţile evoluţiei clinice, complicațiile, rezultatele imediate şi la distanţă ale tratamentului citoreductiv pe un lot de 114 pacienţi cu policitemia vera cu vârsta cuprinsă între 28 şi 78 de ani. Diagnosticul clinic în toate cazurile a fost confirmat prin trepanobiopsia…

  18. Journal Article

    The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas

    Victor Tomacinschii; Adrian Mosquera Orgueira; Carlos Aliste Santos et al.

    Frontiers in Oncology, Vol. 13 · 2023 · English · DOAJ Scopus

    Next generation sequencing (NGS) is a technology that broadens the horizon of knowledge of several somatic pathologies, especially in oncological and oncohematological pathology. In the case of NHL, the understanding of the mechanisms of tumorigenesis, tumor proliferation and the identification of…

  19. Journal Article

    The crosstalk between epigenetics and metabolism in the malignant cell

    Adrian Bogdan Tigu; Andrei Ivancuta; Catalin Sorin Constantinescu et al.

    Discover Oncology, Vol. 17 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Metabolic-epigenetic coupling is recognized as a central hallmark of malignant transformation, characterized by dynamic interplay between cellular metabolism and epigenetic regulation. Cancer cells undergo metabolic reprogramming to meet new demands due to increased biosynthesis and…